➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Merck
Medtronic
Express Scripts
AstraZeneca

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Details for Patent: 10,195,159

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 10,195,159 protect, and when does it expire?

Patent 10,195,159 protects EPIDIOLEX and is included in one NDA.

This patent has nineteen patent family members in eleven countries.

Summary for Patent: 10,195,159
Title:Processes and apparatus for extraction of active substances and enriched extracts from natural products
Abstract: Processes for preparing extracts of natural products such as plant material, and for preparing purified extracts from crude extracts of natural products, by extraction with hot gas. Apparatus suitable for use in preparing extracts of natural products are also described.
Inventor(s): Whittle; Brian Anthony (Hornsea, GB), Guy; Geoffrey (Glansvilles Wooton, GB), Downs; David Victor (Canterbury, GB), Pate; David W. (Amsterdam, NL)
Assignee: GW Pharma Limited (Cambridge, GB)
Application Number:14/674,098
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 10,195,159

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Gw Res Ltd EPIDIOLEX cannabidiol SOLUTION;ORAL 210365-001 Sep 28, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,195,159

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0111046.9May 4, 2001

International Family Members for US Patent 10,195,159

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 555833   Start Trial
Australia 2002255150   Start Trial
Canada 2446195   Start Trial
China 1306979   Start Trial
China 1524007   Start Trial
European Patent Office 1385595   Start Trial
United Kingdom 0111046   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Medtronic
Moodys
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.